Dianthus Therapeutics Inc. Long-term Investment Intensity
Dianthus Therapeutics Inc. long-term investment intensity. Dianthus Therapeutics Inc. (DNTH) has a Long-term Investment Intensity of 25.0% as of June 2026. Long-term investments of $303.63 Million represent 25.0% of total assets of $1.21 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read DNTH current and long-term liabilities for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Dianthus Therapeutics Inc. (2024–2025)
Long-term investment intensity of Dianthus Therapeutics Inc. from 2024 to 2025. This chart shows how Dianthus Therapeutics Inc.'s Long-term Investment Intensity has evolved across 2 annual periods from 2024 to 2025. As of June 2026, the intensity stands at 25.0%, reflecting long-term investments of $303.63 Million against total assets of $1.21 Billion USD.
Dianthus Therapeutics Inc. Long-term Investment Intensity by Year (2024–2025)
Dianthus Therapeutics Inc. long-term investment intensity by year from 2024 to 2025. The table below presents the year-by-year Long-term Investment Intensity for Dianthus Therapeutics Inc. from 2024 to 2025, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see DNTH total assets.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 20.7% | $110.14 Million | $530.92 Million | ▼ -1.1 pp |
| 2024 | 21.9% | $81.73 Million | $374.01 Million | — |